Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' WAINBERG MA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 204 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kijak, GH; Pampuro, SE; Avila, MM; Zala, C; Cahn, P; Wainberg, MA; Salomon, H
      Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina

      ANTIVIRAL THERAPY
    2. Wainberg, MA; White, AJ
      Current insights into reverse transcriptase inhibitor-associated resistance

      ANTIVIRAL THERAPY
    3. Conway, B; Wainberg, MA; Hall, D; Harris, M; Reiss, P; Cooper, D; Vella, S; Curry, R; Robinson, P; Lange, JMA; Montaner, JSG
      Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine

      AIDS
    4. Wainberg, MA
      The global need for microbicides

      AIDS
    5. Wainberg, MA
      Welcome from the conference chairman

      AIDS
    6. Laughrea, M; Shen, N; Jette, L; Darlix, JL; Kleiman, L; Wainberg, MA
      Role of distal zinc finger of nucleocapsid protein in genomic RNA dimerization of human immunodeficiency virus Type 1; No role for the palindrome crowning the R-U5 hairpin

      VIROLOGY
    7. Guan, YJ; Whitney, JB; Detorio, M; Wainberg, MA
      Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted

      JOURNAL OF VIROLOGY
    8. Kameoka, M; Rong, LW; Gotte, M; Liang, C; Russell, RS; Wainberg, MA
      Role for human immunodeficiency virus type 1 Tat protein in suppression ofviral reverse transcriptase activity during late stages of viral replication

      JOURNAL OF VIROLOGY
    9. Guan, YJ; Whitney, JB; Liang, C; Wainberg, MA
      Novel, live attenuated simian immunodeficiency virus constructs containingmajor deletions in leader RNA sequences

      JOURNAL OF VIROLOGY
    10. Guan, YJ; Diallo, K; Detorio, M; Whitney, JB; Liang, C; Wainberg, MA
      Partial restoration of replication of simian immunodeficiency virus by point mutations in either the dimerization initiation site (DIS) or Gag regionafter deletion mutagenesis within the DIS

      JOURNAL OF VIROLOGY
    11. Guan, YJ; Diallo, K; Whitney, JB; Liang, C; Wainberg, MA
      An intact U5-leader stem is important for efficient replication of simian immunodeficiency virus

      JOURNAL OF VIROLOGY
    12. Shen, N; Jette, L; Wainberg, MA; Laughrea, M
      Role of stem B, loop B, and nucleotides next to the primer binding site and the kissing-loop domain in human immunodeficiency virus type 1 replication and genomic-RNA dimerization

      JOURNAL OF VIROLOGY
    13. Rong, LW; Russell, RS; Hu, J; Guan, YJ; Kleiman, L; Liang, C; Wainberg, MA
      Hydrophobic amino acids in the human immunodeficiency virus type 1 p2 and nucleocapsid proteins can contribute to the rescue of deleted viral RNA packaging signals

      JOURNAL OF VIROLOGY
    14. Gotte, M; Kameoka, M; McLellan, N; Cellai, L; Wainberg, MA
      Analysis of efficiency and fidelity of HIV-1 (+)-strand DNA synthesis reveals a novel rate-limiting step during retroviral reverse transcription

      JOURNAL OF BIOLOGICAL CHEMISTRY
    15. Diallo, K; Loemba, H; Oliveira, M; Mavoungou, DD; Wainberg, MA
      Inhibition of human immunodeficiency virus type-1 (HIV-1) replication by Immunor (IM28), a new analog of dehydroepiandrosterone

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    16. Gotte, M; Wainberg, MA
      Biochemical mechanisms involved in overcoming HIV resistance to nucleosideinhibitors of reverse transcriptase

      DRUG RESISTANCE UPDATES
    17. Hsu, M; Wainberg, MA
      Interactions between human immunodeficiency virus type 1 reverse transcriptase, tRNA primer, and nucleocapsid protein during reverse transcription

      JOURNAL OF HUMAN VIROLOGY
    18. Richard, N; Salomon, H; Oliveira, M; Rando, R; Mansour, T; Gu, ZX; Wainberg, MA
      Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    19. Brenner, B; Wainberg, MA; Salomon, H; Rouleau, D; Dascal, A; Spira, B; Sekaly, RP; Conway, B; Routy, JP
      Resistance to antiretroviral drugs in patients with primary HIV-1 infection

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    20. Hsu, M; Rong, LW; de Rocquigny, H; Roques, BP; Wainberg, MA
      The effect of mutations in the HIV-1 nucleocapsid protein on strand transfer in cell-free reverse transcription reactions

      NUCLEIC ACIDS RESEARCH
    21. Wei, X; Gotte, M; Wainberg, MA
      Human immunodeficiency virus type-1 reverse transcription can be inhibitedin vitro by oligonucleotides that target both natural and synthetic tRNA primers

      NUCLEIC ACIDS RESEARCH
    22. Salomon, H; Wainberg, MA; Brenner, B; Quan, YD; Rouleau, D; Cote, P; LeBlanc, R; Lefebvre, E; Spira, B; Tsoukas, C; Sekaly, RP; Conway, B; Mayers, D; Routy, JP
      Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use

      AIDS
    23. Richard, N; Salomon, H; Rando, R; Mansour, T; Bowlin, TL; Wainberg, MA
      Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2 '-deoxy-3 '-oxa-4 '-thio-5-fluorocytidine

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    24. Delaney, M; Grinberg, L; Harrington, M; Morris, L; Wainberg, MA; Moore, JP
      Why are AIDS dissidents still making 15-year-old, long-refuted claims?

      NATURE
    25. Gotte, M; Arion, D; Parniak, MA; Wainberg, MA
      The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis

      JOURNAL OF VIROLOGY
    26. Cen, S; Khorchid, A; Gabor, J; Rong, LW; Wainberg, MA; Kleiman, L
      Roles of Pr55(gag) and NCp7 in tRNA(3)(LYS) genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1

      JOURNAL OF VIROLOGY
    27. Guan, YJ; Whitney, JB; Diallo, K; Wainberg, MA
      Leader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus

      JOURNAL OF VIROLOGY
    28. Liang, C; Rong, LW; Russell, RS; Wainberg, MA
      Deletion mutagenesis downstream of the 5 ' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene

      JOURNAL OF VIROLOGY
    29. Shen, N; Jette, L; Liang, C; Wainberg, MA; Laughrea, M
      Impact of human immunodeficiency virus type 1 RNA dimerization on viral infectivity and of stem-loop B on RNA dimerization and reverse transcription and dissociation of dimerization from packaging

      JOURNAL OF VIROLOGY
    30. Khorchid, A; Javanbakht, H; Wise, S; Halwani, R; Parniak, MA; Wainberg, MA; Kleiman, L
      Sequences within Pr160gag-pol affecting the selective packaging of primer tRNA(Lys3) into HIV-1

      JOURNAL OF MOLECULAR BIOLOGY
    31. Kang, CY; Luo, LZ; Wainberg, MA; Li, Y
      Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles

      BIOLOGICAL CHEMISTRY
    32. Quan, YD; Motakis, D; Buckheit, R; Xu, ZQ; Flavin, MT; Parniak, MA; Wainberg, MA
      Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptase

      ANTIVIRAL THERAPY
    33. Richard, N; Quan, YD; Salomon, H; Hsu, M; Bedard, J; Harrigan, PR; Rando, R; Mansour, T; Bowlin, TL; Wainberg, MA
      Selection and characterization of HIV-1 variants resistant to the (+) and (-) enantiomers of 2 '-deoxy-3 '-oxa-4 '-thiocytidine (dOTC)

      ANTIVIRAL THERAPY
    34. Wainberg, MA; Miller, MD; Quan, YD; Salomon, H; Mulato, AS; Lamy, PD; Margot, NA; Anton, KE; Cherrington, JM
      In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA

      ANTIVIRAL THERAPY
    35. Lin, PF; Gonzalez, CJ; Griffith, B; Friedland, G; Calvez, V; Ferchal, F; Schinazi, RF; Shepp, DH; Ashraf, AB; Wainberg, MA; Soriano, V; Mellors, JW; Colonno, RJ
      Stavudine resistance: an update on susceptibility following prolonged therapy

      ANTIVIRAL THERAPY
    36. Wainberg, MA
      The endless tragedy of pediatric AIDS

      JOURNAL OF HUMAN VIROLOGY
    37. Wainberg, MA
      South Africa must admit that HIV AIDS is its greatest enemy

      BRITISH MEDICAL JOURNAL
    38. Germinario, RJ; Colby-Germinario, SP; Acel, A; Chandok, R; Davison, K; Mak, J; Kleiman, L; Faust, E; Wainberg, MA
      Effect of insulin-like growth factor I on HIV type 1 long terminal repeat-driven chloramphenicol acetyltransferase expression

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    39. Wainberg, MA
      The need for microbicides: Why aren't women's groups more involved in the fight against AIDS?

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    40. Hsu, M; Cherry, E; Quan, Y; Richard, N; Kleiman, L; Wainberg, MA
      Effect of mutations in NC7 on endogenous reverse transcription in HIV-1

      LEUKEMIA
    41. Richard, N; Salomon, H; Oliveira, M; Rando, R; Wainberg, MA
      Resistance profiles of (+)2 '-deoxy-3 '-oxa-4 '-thiocytidine and (-)2 '-deoxy-3 '-oxa-4 '-thio-5-fluorocytidine.

      NUCLEOSIDES & NUCLEOTIDES
    42. Gu, ZX; Wainberg, MA; Nguyen-Ba, P; L'Heureux, L; de Muys, JM; Rando, RF
      Anti-HIV-1 activities of 1,3-dioxolane guanine and 2,6-diaminopurine dioxolane

      NUCLEOSIDES & NUCLEOTIDES
    43. Machado, J; Salomon, H; Oliveira, M; Tsoukas, C; Krayevsky, AA; Wainberg, MA
      Antiviral activity and resistance profile of phosphazid - A novel prodrug of AZT

      NUCLEOSIDES & NUCLEOTIDES
    44. Wainberg, MA
      Letter from the President

      AIDS
    45. Rubsamen-Waigmann, H; Huguenel, E; Shah, A; Paessens, A; Ruoff, HJ; von Briesen, H; Immelmann, A; Dietrich, U; Wainberg, MA
      Resistance mutations selected in vivo under therapy with anti-HIV drug HBY097 differ from resistance pattern selected in vitro

      ANTIVIRAL RESEARCH
    46. Wainberg, MA
      A new source of resistance to HIV drugs

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    47. de Muys, JM; Gourdeau, H; Nguyen-Ba, N; Taylor, DL; Ahmed, PS; Mansour, T; Locas, C; Richard, N; Wainberg, MA; Rando, RF
      Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2 '-deoxy-3 '-oxa-4 '-thiocytidine

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    48. Borkow, G; Arion, D; Wainberg, MA; Parniak, MA
      The thiocarboxanilide nonnucleoside inhibitor UC781 restores antiviral activity of 3 '-azido-3 '-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus type 1

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    49. Gu, ZX; Wainberg, MA; Nguyen-Ba, N; L'Heureux, L; de Muys, JM; Bowlin, TL; Rando, RF
      Mechanism of action and in vitro activity of 1 ',3 '-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    50. Genin, P; Mamane, Y; Kwon, H; LePage, C; Wainberg, MA; Hiscott, J
      Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells

      VIROLOGY
    51. Wainberg, MA
      Say no to boycott of AIDS conference

      NATURE
    52. Quan, YD; Rong, LW; Liang, C; Wainberg, MA
      Reverse transcriptase inhibitors can selectively block the synthesis of differently sized viral DNA transcripts in cells acutely infected with human immunodeficiency virus type 1

      JOURNAL OF VIROLOGY
    53. Liang, C; Rong, LW; Quan, YD; Laughrea, M; Kleiman, L; Wainberg, MA
      Mutations within four distinct Gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site

      JOURNAL OF VIROLOGY
    54. Cen, S; Huang, YE; Khorchid, A; Darlix, JL; Wainberg, MA; Kleiman, L
      The role of Pr55(gag) in the annealing of tRNA44(3)(Lys) to human immunodeficiency virus type 1 genomic RNA

      JOURNAL OF VIROLOGY
    55. Gotte, M; Maier, G; Onori, AM; Cellai, L; Wainberg, MA; Heumann, H
      Temporal coordination between initiation of HIV (+)-strand DNA synthesis and primer removal

      JOURNAL OF BIOLOGICAL CHEMISTRY
    56. Laughrea, M; Shen, N; Jette, L; Wainberg, MA
      Variant effects of non-native kissing-loop hairpin palindromes on HIV replication and HIV RNA dimerization: Role of stem-loop B in HIV replication and HIV RNA dimerization

      BIOCHEMISTRY
    57. Gotte, M; Li, XG; Wainberg, MA
      HIV-1 reverse transcription: A brief overview focused on structure-function relationships among molecules involved in initiation of the reaction

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    58. WAINBERG MA; CAMERON DW
      HIV RESISTANCE TO ANTIVIRAL DRUGS - PUBLIC-HEALTH IMPLICATIONS

      DRUG RESISTANCE UPDATES
    59. SALOMON H; MONTANER JSG; BELMONTE A; WAINBERG MA
      DIMINISHED HIV-1 SENSITIVITY TO STAVUDINE IN PATIENTS ON PROLONGED THERAPY OCCURS ONLY AT LOW-LEVELS AND CANNOT BE ATTRIBUTED TO ANY SINGLEAMINO-ACID SUBSTITUTION IN REVERSE-TRANSCRIPTASE

      Antiviral therapy
    60. CARO C; COLBYGERMINARIO S; BRENNER B; OLVEIRA M; WAINBERG MA; GERMINARIO RJ
      SUGAR-TRANSPORT AND GLUT TRANSPORTER EXPRESSION IN A VARIETY OF HUMANIMMUNODEFICIENCY VIRUS-1 (HIV-1) CHRONICALLY INFECTED TARGET-CELL LINES

      International journal of biochemistry & cell biology
    61. DROSOPOULOS WC; REZENDE LF; WAINBERG MA; PRASAD VR
      VIRTUES OF BEING FAITHFUL - CAN WE LIMIT THE GENETIC-VARIATION IN HUMAN-IMMUNODEFICIENCY-VIRUS

      Journal of molecular medicine
    62. INOUYE P; CHERRY E; HSU M; ZOLLAPAZNER S; WAINBERG MA
      NEUTRALIZING ANTIBODIES DIRECTED AGAINST THE V3 LOOP SELECT FOR DIFFERENT ESCAPE VARIANTS IN A VIRUS WITH MUTATED REVERSE-TRANSCRIPTASE (M184V) THAN IN WILD-TYPE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      AIDS research and human retroviruses
    63. TSOUKAS CM; RABOUD J; BERNARD NF; MONTANER JSG; GILL MJ; RACHLIS A; FONG IW; SCHLECH W; DJURDJEV O; FREEDMAN J; THOMAS R; LAFRENIERE R; WAINBERG MA; CASSOL S; OSHAUGHNESSY M; TODD J; VOLVOVITZ F; SMITH GE
      ACTIVE IMMUNIZATION OF PATIENTS WITH HIV-INFECTION - A STUDY OF THE EFFECT OF VAXSYN, A RECOMBINANT HIV ENVELOPE SUBUNIT VACCINE, ON PROGRESSION OF IMMUNODEFICIENCY

      AIDS research and human retroviruses
    64. Quan, YD; Liang, C; Inouye, P; Wainberg, MA
      Enhanced impairment of chain elongation by inhibitors of HIV reverse transcriptase in cell-free reactions yielding longer DNA products

      NUCLEIC ACIDS RESEARCH
    65. CHERRY E; MORIN N; WAINBERG MA
      EFFECT OF HIV CONSTRUCTS CONTAINING PROTEASE REVERSE-TRANSCRIPTASE FUSION PROTEINS ON VIRAL REPLICATION

      AIDS
    66. FOLI A; MASERATI R; MINOLI L; WAINBERG MA; GALLO RC; LISZIEWICZ J; LORI F
      THERAPEUTIC ADVANTAGE OF HYDROXYUREA AND DIDANOSINE COMBINATION THERAPY IN PATIENTS PREVIOUSLY TREATED WITH ZIDOVUDINE

      AIDS
    67. FRIEDMAN SR; WAINBERG MA; DRUCKER E
      THERAPEUTIC ETHICS AND COMMUNITIES AT RISK IN THE PRESENCE OF POTENTIAL MUTATION TO RESISTANT STRAINS TO HIV ANTIVIRAL MEDICATIONS

      AIDS
    68. BERNARD NF; PEDERSON K; CHUNG F; OUELLET L; WAINBERG MA; TSOUKAS CM
      HIV-SPECIFIC CYTOTOXIC T-LYMPHOCYTE ACTIVITY IN IMMUNOLOGICALLY NORMAL HIV-INFECTED PERSONS

      AIDS
    69. RAE S; RABOUD JM; CONWAY B; REISS P; VELLA S; COOPER D; LANGE J; HARRIS M; WAINBERG MA; ROBINSON P; MYERS M; HALL D; MONTANER JSG
      ESTIMATES OF THE VIROLOGICAL BENEFIT OF ANTIRETROVIRAL THERAPY ARE BOTH ASSAY-DEPENDENT AND ANALYSIS-DEPENDENT

      AIDS
    70. RABOUD JM; MONTANER JSG; CONWAY B; RAE S; REISS P; VELLA S; COOPER D; LANGE O; HARRIS M; WAINBERG MA; ROBINSON P; MYERS M; HALL D
      SUPPRESSION OF PLASMA VIRAL LOAD BELOW 20 COPIES ML IS REQUIRED TO ACHIEVE A LONG-TERM RESPONSE TO THERAPY/

      AIDS
    71. WAINBERG MA; FRIEDLAND G
      IMPROVING PATIENT COMPLIANCE WITH HIV TREATMENT REGIMENS - REPLY

      JAMA, the journal of the American Medical Association
    72. WAINBERG MA; FRIEDLAND G
      PUBLIC-HEALTH IMPLICATIONS OF ANTIRETROVIRAL THERAPY AND HIV DRUG-RESISTANCE

      JAMA, the journal of the American Medical Association
    73. MONTANER JSG; REISS P; COOPER D; VELLA S; HARRIS M; CONWAY B; WAINBERG MA; SMITH D; ROBINSON P; HALL D; MYERS M; LANGE JMA
      A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING COMBINATIONS OF NEVIRAPINE, DIDANOSINE, AND ZIDOVUDINE FOR HIV-INFECTED PATIENTS - THE INCAS TRIAL

      JAMA, the journal of the American Medical Association
    74. DELUCA C; KWON H; PELLETIER N; WAINBERG MA; HISCOTT J
      NF-KAPPA-B PROTECTS HIV-1-INFECTED MYELOID CELLS FROM APOPTOSIS

      Virology
    75. LIANG C; RONG LW; LAUGHREA M; KLEIMAN L; WAINBERG MA
      COMPENSATORY POINT MUTATIONS IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG REGION THAT ARE DISTAL FROM DELETION MUTATIONS IN THE DIMERIZATION INITIATION SITE CAN RESTORE VIRAL REPLICATION

      Journal of virology
    76. ARTS EJ; QUINONESMATEU ME; ALBRIGHT JL; MAROIS JP; HOUGH C; GU ZX; WAINBERG MA
      3'-AZIDO-3'-DEOXYTHYMIDINE (AZT) MEDIATES CROSS-RESISTANCE TO NUCLEOSIDE ANALOGS IN THE CASE OF AZT-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS

      Journal of virology
    77. HUANG Y; KHORCHID A; GABOR J; WANG J; LI XG; DARLIX JL; WAINBERG MA; KLEIMAN L
      THE ROLE OF NUCLEOCAPSID AND U5 STEM A-RICH LOOP SEQUENCES IN TRNA(3)(LYS) GENOMIC PLACEMENT AND INITIATION OF REVERSE TRANSCRIPTION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1/

      Journal of virology
    78. ACEL A; UDASHKIN BE; WAINBERG MA; FAUST EA
      EFFICIENT GAP REPAIR CATALYZED IN-VITRO BY AN INTRINSIC DNA-POLYMERASE-ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE

      Journal of virology
    79. RONG LW; LIANG C; HSU ML; KLEIMAN L; PETITJEAN P; DEROCQUIGNY H; ROQUES BP; WAINBERG MA
      ROLES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NUCLEOCAPSID PROTEININ ANNEALING AND INITIATION VERSUS ELONGATION IN REVERSE TRANSCRIPTION OF VIRAL NEGATIVE-STRAND STRONG-STOP DNA

      Journal of virology (Print)
    80. CHERRY E; LIANG C; RONG LW; QUAN YD; INOUYE P; LI XG; MORIN N; KOTLER N; WAINBERG MA
      CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PARTICLES THAT EXPRESS PROTEASE-REVERSE TRANSCRIPTASE FUSION PROTEINS

      Journal of Molecular Biology
    81. QUAN YD; GU ZX; LI XG; LIANG C; PARNIAK MA; WAINBERG MA
      ENDOGENOUS REVERSE-TRANSCRIPTASE ASSAYS REVEAL SYNERGY BETWEEN COMBINATIONS OF THE M184V AND OTHER DRUG RESISTANCE-CONFERRING MUTATIONS IN INTERACTIONS WITH NUCLEOSIDE ANALOG TRIPHOSPHATES

      Journal of Molecular Biology
    82. MAYERS D; BETHEL J; WAINBERG MA; WEISLOW O; SCHNITTMAN S
      HUMAN-IMMUNODEFICIENCY-VIRUS PROVIRAL DNA FROM PERIPHERAL-BLOOD AND LYMPH-NODES DEMONSTRATES CONCORDANT RESISTANCE MUTATIONS TO ZIDOVUDINE (CODON-215) AND DIDANOSINE (CODON-74)

      The Journal of infectious diseases
    83. QUAN YD; INOUYE P; LIANG C; RONG LW; GOTTE M; WAINBERG MA
      DOMINANCE OF THE E89G SUBSTITUTION IN HIV-1 REVERSE-TRANSCRIPTASE IN REGARD TO INCREASED POLYMERASE PROCESSIVITY AND PATTERNS OF PAUSING

      The Journal of biological chemistry
    84. LIANG C; RONG LW; GOTTE M; LI XG; QUAN YD; KLEIMAN L; WAINBERG MA
      MECHANISTIC STUDIES OF EARLY PAUSING EVENTS DURING INITIATION OF HIV-1 REVERSE TRANSCRIPTION

      The Journal of biological chemistry
    85. KWON H; PELLETIER N; DELUCA C; GENIN P; CISTERNAS S; LIN BT; WAINBERG MA; HISCOTT J
      INDUCIBLE EXPRESSION OF I-KAPPA-B-ALPHA REPRESSOR MUTANTS INTERFERES WITH NF-KAPPA-B ACTIVITY AND HIV-1 REPLICATION IN JURKAT T-CELLS

      The Journal of biological chemistry
    86. SOUDEYNS H; WAINBERG MA
      EFFECTS OF RU486 ON HIV-1 REPLICATION

      Nature medicine
    87. CONTI L; HISCOTT J; PAPACCHINI M; ROULSTON A; WAINBERG MA; BELARDELLI F; GESSANI S
      INDUCTION OF RELA(P65) AND I-KAPPA-B-ALPHA SUBUNIT EXPRESSION DURING DIFFERENTIATION OF HUMAN PERIPHERAL-BLOOD MONOCYTES TO MACROPHAGES

      Cell growth & differentiation
    88. LORI F; MALYKH AG; FOLI A; MASERATI R; DEANTONI A; MINOLI L; PADRINI DA; DEGLIANTONI A; BARCHI E; JESSEN H; WAINBERG MA; GALLO RC; LISZIEWICZ J
      COMBINATION OF A DRUG TARGETING THE CELL WITH A DRUG TARGETING THE VIRUS CONTROLS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANCE

      AIDS research and human retroviruses
    89. RICHARD N; BELMONTE AR; SALOMON H; NAGAI K; MANSOUR T; WAINBERG MA
      RESISTANCE PROFILE OF A NOVEL 2',3'-DIDEOXYNUCLEOSIDE ANALOG WITH ACTIVITY AGAINST HIV-1

      Nucleosides & nucleotides
    90. ANAZODO MI; DUTA E; SALOMON H; FRIESEN AD; WAINBERG MA; WRIGHT JA
      CHARACTERIZATION OF GPI2A, A POTENT INHIBITOR OF HIV-1 GENE-EXPRESSION AND VIRAL REPLICATION

      Nucleosides & nucleotides
    91. HSU ML; INOUYE P; REZENDE L; RICHARD N; LI Z; PRASAD VR; WAINBERG MA
      HIGHER FIDELITY OF RNA-DEPENDENT DNA MISPAIR EXTENSION BY M184V DRUG-RESISTANT THAN WILD-TYPE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Nucleic acids research
    92. LI XG; QUAN YD; WAINBERG MA
      CONTROLLING ELEMENTS IN REPLICATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Cellular and molecular biology
    93. RUBSAMENWAIGMANN H; HUGUENEL E; PAESSENS A; KLEIM JP; WAINBERG MA; SHAH A
      2ND-GENERATION NON-NUCLEOSIDIC REVERSE-TRANSCRIPTASE INHIBITOR HBY097AND HIV-1 VIRAL LOAD

      Lancet
    94. CHERRY E; SLATER M; SALOMON H; RUD E; WAINBERG MA
      MUTATIONS AT CODON-184 IN SIMIAN IMMUNODEFICIENCY VIRUS REVERSE-TRANSCRIPTASE CONFER RESISTANCE TO THE (-) ENANTIOMER OF 2',3'-DIDEOXY-3'-THIACYTIDINE

      Antimicrobial agents and chemotherapy
    95. PRASAD VR; DROSOPOULOS WC; WAINBERG MA
      REVERSE-TRANSCRIPTASE FIDELITY AND HIV-1 VARIATION - RESPONSE

      Science
    96. LIANG C; LI XG; RONG LW; INOUYE P; QUAN YD; KLEIMAN L; WAINBERG MA
      THE IMPORTANCE OF THE A-RICH LOOP IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE TRANSCRIPTION AND INFECTIVITY

      Journal of virology
    97. LI XG; LIANG C; QUAN YD; CHANDOK R; LAUGHREA M; PARNIAK MA; KLEIMAN L; WAINBERG MA
      IDENTIFICATION OF SEQUENCES DOWNSTREAM OF THE PRIMER BINDING-SITE THAT ARE IMPORTANT FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Journal of virology
    98. HUANG Y; KHORCHID A; WANG J; PARNIAK MA; DARLIX JL; WAINBERG MA; KLEIMAN L
      EFFECT OF MUTATIONS IN THE NUCLEOCAPSID PROTEIN (NCP7) UPON PR160(GAG-POL) AND TRNA(LYS) INCORPORATION INTO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Journal of virology
    99. LAUGHREA M; JETTE L; MAK J; KLEIMAN L; LIANG C; WAINBERG MA
      MUTATIONS IN THE KISSING-LOOP HAIRPIN OF HUMAN-IMMUNODEFICIENCY-VIRUSTYPE-1 REDUCE VIRAL INFECTIVITY AS WELL AS GENOMIC RNA PACKAGING AND DIMERIZATION

      Journal of virology
    100. BORKOW G; BARNARD J; NGUYEN TM; BELMONTE A; WAINBERG MA; PARNIAK MA
      CHEMICAL BARRIERS TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION - RETROVIRUCIDAL ACTIVITY OF UC781, A THIOCARBOXANILIDE NONNUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE

      Journal of virology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 02:07:47